Is Cash Value Life Insurance a Good Investment? The Real Rate of Return

Jordan is standing at the kitchen counter at 11 p.m., laptop propped against the fruit bowl, coffee gone cold an hour ago. The email came from a college roommate — three years into selling life insurance now — with the subject line "this could actually change your retirement." Attached is a seven-page illustration. Page four has a chart that curves upward toward $340,000 of projected tax-free income starting at 65. It doesn't look like an insurance policy. It looks like a retirement plan nobody bothered to mention before.

Twenty minutes later, unable to let it go, Jordan opens a second tab — a personal finance forum, a thread pushing 400 replies, top comment calling the exact same category of product a garbage return dressed up in a suit, sold to people who trust their college roommates more than their calculators.

Both verdicts sound certain. Both can't be right. And here's what neither tab tells Jordan: they're actually answering two different questions, and neither one says which question it's answering.

I'll say this plainly, and it's going to sound strange in an article titled "is this a good investment": life insurance is not an investment. Investments carry no guarantees — that's the defining feature of an investment. You take on risk, and the market decides what you get back. Many cash value life insurance contracts carry contractual guarantees. That's the defining feature of insurance. The moment something is guaranteed, it has stopped being a bet on an outcome and become a transfer of risk to the carrier. So before I answer the question in the title, I want to question the premise of the question itself.

That's not a dodge, and it's not a satisfying place to end an article, so I'm going to grade it against the right category anyway — the honest version, not the version built to close a sale.

One more thing before we start: this article draws a hard line from a companion piece, Is Cash Value Life Insurance Worth It? That one asks whether the policy fits your financial life at all — a question about need. This one doesn't touch fit. It treats the policy strictly as a machine that takes premium dollars in and produces a dollar-denominated return, and grades it on that basis alone.

Grading the Return: Short-Term vs. Long-Term

Here's where almost every hot take you'll read online — in either direction — quietly picks one time horizon and pretends it's the whole story. The honest answer requires both.

The Short-Term Verdict (Roughly Years 1–10)

I'm going to concede this fully, because it's true and dressing it up would cost me your trust for the rest of this article. Underwriting, medical exams, administrative setup, and contract capitalization costs are front-loaded. In the earliest years, your cash value's internal rate of return is functionally flat or negative — you can read the full mechanics of exactly where those dollars go in The Internal Drag: Cost-of-Insurance Charges. As the policy moves through years four through ten, the curve starts climbing toward breakeven as the cost of insurance gets spread across a growing cash value base.

If you need this money inside a decade, or you're grading the product only across this window, the "bad investment" verdict is correct. I'm not going to argue with it.

The Long-Term Verdict (Year 15 and Beyond)

This is where the picture changes — not because the early costs disappear, but because they stop being the whole story. Once a properly funded, non-MEC policy is well past its front-loaded years, the cost of insurance settles as a smaller share of a larger base, and compounding on the guaranteed schedule of cash values (for participating whole life) or the declared rate (for fixed universal life) starts doing real work.

I'm not going to hand you a stabilized percentage here, and I want to tell you exactly why: it depends on the carrier, the dividend scale, the product design, and how aggressively the policy was funded relative to its face amount. A dividend-optimized whole life contract from a strong mutual carrier behaves differently than a thinly funded, commission-loaded one — and any single number presented as "the" rate of return on cash value life insurance is doing you a disservice by pretending those design differences don't exist.

The Invalid Baseline: Why You Can't Compare This to the S&P 500

An index fund tracks corporate equities carrying full principal risk. A whole life contract — and, to a lesser extent, fixed universal life — carries a contractual floor backed by the carrier's general account. Comparing whole life cash value to a growth-stock index fund is like grading a treasury bill on how it performed against a tech stock. That's not a controversial opinion. It's a category error, and it's the single most common mistake made by both the sales pitches and the takedowns.

I want to engage the strongest version of the opposing case here, not a strawman, so let's look at exactly what the most prominent critics actually say.

Dave Ramsey has built a substantial part of his platform around this critique, and his math is specific: for every $100 paid in whole life premium, roughly $5 buys the death benefit and $95 funds the cash value — and, on his account, the first three years of that $95 go entirely to fees. He cites a nationally averaged return on that portion, zero years included, of around 1.2%, which he then measures against an assumed mutual fund return in the 10% to 12% range.

Here's my concession: graded across the earliest years of a traditionally designed, commission-heavy policy, that math isn't fabricated. It's real, and I've sat across the table from clients living through exactly that curve.

Here's my pushback: the other side of that comparison doesn't hold up nearly as well. A flat 10–12% mutual fund return, held constant forever with no accounting for sequence risk, volatility, or the well-documented gap between what markets return and what investors actually capture net of their own behavior, isn't a fair baseline either. And a 1.2% figure describes one specific policy design — commission-loaded, minimally structured — not the category. A policy funded with paid-up additions rather than base premium alone can produce a meaningfully different early-years curve, without changing anything about the honest concession above: this was never going to out-race equities, and it isn't supposed to.

Suze Orman's position is more categorical: insurance and investments should never be combined, full stop. But there's a piece of her advice I agree with completely, and it's worth pulling out on its own — she tells people to look at the guaranteed cash value and guaranteed death benefit, not the illustrated projection. That's the exact same instruction I give every client sitting across from an illustration. It's good advice regardless of which side of this debate you land on.

For a deeper look at why mainstream financial media leans so hard toward blanket dismissal rather than the harder, more nuanced answer, see Why Does the Financial Media Hate Whole Life Insurance? And if the anxiety driving your search is less "which camp is right" and more "what did I actually give up by not investing this money instead," that fear has a name — see Opportunity Cost in Personal Finance.

On the opposite extreme, you'll find people selling the idea that whole life is a "wealth multiplier" you can borrow against infinitely at no real cost. That claim doesn't hold up any better than Ramsey's — I've addressed it directly elsewhere and won't re-argue it here: see why you don't make money borrowing against your own policy.

The Valid Baseline: Cash Value as a Fixed-Income Alternative

Here's the comparison that actually applies. Traditional fixed-income holdings — CDs, high-yield savings, most bonds held outside a retirement account — throw off ordinary taxable interest every single year. For a high earner, a nominal 4–5% yield shrinks fast once federal and state income tax take their share, every year, whether you touch the money or not.

Cash value inside a properly structured, non-MEC policy grows tax-deferred by design — this isn't a marketing phrase, it's a specific mechanism defined in the federal tax code. Section 7702 sets the requirements a contract has to meet to qualify for that treatment in the first place.

Accessing that value correctly matters as much as the growth itself. Withdrawals up to your cost basis — what you've paid in — come out tax-free, because they're a return of your own money, not a gain. Beyond basis, the standard tool is a policy loan, and I want to be precise about what that actually is: a lien against your cash value, not a withdrawal and not a "line of credit" in the way a bank would use that term. Your gross cash value keeps compounding on its full balance even while a loan is outstanding — the loan reduces your net position, not the cash value itself, and it accrues interest that either gets repaid or reduces the death benefit if it's still outstanding at death.

For the direct numbers comparison against treasuries and traditional bonds, see Repositioned Cash: Life Insurance vs. Bonds — I won't re-run that math here.

None of this works if the death benefit and funding level weren't sized correctly to begin with — an oversized or undersized policy distorts every number in this article. Before assuming any figure an illustration hands you is the right one, it's worth running your actual numbers through our life insurance needs calculator.

The Other Long-Term Comparison Nobody Runs: Front-Loaded Cost vs. Perpetual AUM Drag

You've now heard the honest case against this product's cost structure: it's front-loaded, and the earliest years are genuinely expensive. Here's the comparison that almost never gets set next to it. A standard fee-based advisory relationship — charging roughly 1% of assets under management annually — doesn't charge that fee once. It charges it every year, forever, on a balance that's hopefully growing, which means the dollar cost compounds right alongside the portfolio it's drawn from.

The SEC's own investor-education materials illustrate exactly how much this matters. In one of their published examples, a hypothetical $100,000 portfolio growing at a modest 4% annually over 20 years ends up worth roughly $208,000 under a 0.25% annual fee — but only about $179,000 under a 1% annual fee. That's nearly $30,000 of difference, purely from the compounding effect of a fee that never stops being charged. You can review the full example directly at Investor.gov's guide to understanding fees.

Insurance costs run in the opposite direction: heaviest in the first few years, then shrinking as a share of a growing cash value base, then flat to declining as the policy matures. It's a front-loaded, essentially self-limiting cost curve — not a perpetual percentage tax on the entire balance for as long as you hold it.

Neither structure is free, and I'm not selling you "no cost" — I'm making a narrower point: "front-loaded" and "expensive over thirty years" are not the same claim, and conflating them is one of the more common mistakes I see in this comparison, from both sides of the argument.

I'll note directly, because it's relevant here: I also run a fee-based advisory practice through Stormathrive, so I have a direct stake in how this particular comparison lands — in either direction. I'm making the point anyway because it's true, and because the same math applies to any advisory fee I could be charging you as it does to anyone else's.

Grading the Four Contracts on Return Character

"Cash value life insurance" isn't one product — it's four, and they carry meaningfully different return profiles. Here's how they actually behave, graded specifically on return character rather than overall fit.

Contract Type	Growth Mechanism	Guarantee Floor	What Actually Drives the Yield
Whole Life (Participating)	Guaranteed schedule of cash values, enhanced by dividends	Contractual, set at issue	Carrier's general-account performance, mortality experience, and expense savings — smoothed, not market-timed
Fixed Universal Life	Declared interest rate, set at insurer discretion	Contractual minimum floor	Insurer's crediting decisions, loosely tied to the interest rate cycle
Indexed Universal Life	Market-linked crediting formula; money stays in the general account	0% floor on crediting — not on cost-of-insurance drain	The cap and participation rate, which compress when option pricing gets more expensive
Variable Universal Life	Direct market participation in subaccounts	None	Actual subaccount performance — full upside, full downside

One row deserves its own explanation, because it's the clearest illustration of this article's whole thesis. Variable universal life is the only one of these four contracts without a guarantee floor — which means it's the only one that's genuinely an investment product, built on an insurance chassis, rather than an insurance product with investment characteristics. That's exactly why it can't be sold by just any licensed insurance agent. Selling VUL requires the agent to also be appointed and dual-licensed as a FINRA-registered representative of a broker-dealer, and to deliver a prospectus before the sale — the same regulatory scaffolding that applies to any other security. That's not bureaucratic overkill. It's the regulatory system agreeing with the point I opened this article with.

I owned a VUL policy back in 2001, years before I ever held an insurance license — I was a consumer, not an agent, watching my own account value decline in real time during that downturn, the same way any equity account can. The "no floor" line in that table isn't theoretical to me. It's the reason I understand, firsthand, what that risk actually feels like on the other side of the contract.

Knowing what I know now, a straight surrender isn't always the only move if you're holding an underperforming VUL contract during a downturn. A properly executed 1035 exchange can move that remaining cash value tax-free into a stable, guaranteed whole life contract or an annuity, preserving your original cost basis instead of locking in a loss with no offsetting tax benefit — a non-deductible loss on a life insurance surrender doesn't work the way a capital loss would. It's not automatic and it's not right for every situation, so I'd rather point you to the full mechanics than oversimplify them here: see The 1035 Exchange: Moving Cash Value Tax-Free.

That's the traditional commissioned pathway for VUL. Stormathrive's access to it works differently: Decision Tree Insurance LLC is not SEC-registered and cannot sell variable products directly. Where VUL is genuinely the right tool for someone's situation, Stormathrive Wealth Management — the registered investment advisory firm I also own — may be able to provide advisory access to variable products through a managed account structure.

That's the traditional commissioned pathway for VUL. Stormathrive's access to it works differently: Decision Tree Insurance LLC is not SEC-registered and cannot sell variable products directly. Where VUL is genuinely the right tool for someone's situation, Stormathrive Wealth Management — the registered investment advisory firm I also own — may be able to provide advisory access to variable products through a managed account structure.

Jordan, By the Numbers

Back to that kitchen counter. Jordan maxes their 401(k) and a Roth IRA every year. Beyond that, there's a taxable brokerage account sitting mostly in high-yield savings and short-term bonds — the "safe money" portion of the plan — earning a nominal rate that shrinks every April once federal and state tax take their cut. Jordan also pays a financial advisor a standard 1% AUM fee on the whole portfolio, savings sleeve included.

Graded on the short-term lens, a whole life policy would have looked exactly as bad as the forum thread warned — flat-to-negative early years, a real commitment, no quick win. Graded against the S&P 500, it never had a chance and was never supposed to. But graded against what that specific slice of Jordan's portfolio was actually doing — sitting in taxable short-term instruments, quietly losing ground to tax drag every year, inside an advisory relationship charging a perpetual percentage on the balance — the comparison looked different.

Jordan didn't fire the advisor, and didn't buy into a wealth-multiplier pitch either. Jordan repositioned a portion of the cash-and-bonds sleeve that was already underperforming into a modestly funded, properly structured whole life contract — money that's now guaranteed not to go backward, growing tax-deferred, and not throwing off a 1099 every year it's left alone. The brokerage account, the 401(k), and the Roth didn't change at all.

That's what it looks like to grade this correctly — against the category it belongs to, over the time horizon that actually applies.

Frequently Asked Questions

What is the average historical rate of return on cash value life insurance?

There isn't one honest number, and I'd be misleading you to hand you one. It depends on the carrier, the dividend scale or declared rate, the specific product design, and how the policy was funded relative to its death benefit. What's consistent across a properly funded, non-MEC policy from a financially strong carrier is the shape of the curve — flat or negative in the earliest years, climbing through breakeven, then stabilizing into a modest, contractually-anchored yield over the long term. The specific number that curve lands on will vary by policy.

Why does Dave Ramsey say whole life insurance is a bad investment?

Ramsey's specific math — roughly $5 of every $100 in premium buying the death benefit, the remaining $95 funding cash value, three years of fees before any growth, and a nationally averaged early return around 1.2% — describes a real, traditionally designed, commission-heavy policy accurately. Where his analysis breaks down is the comparison on the other side: a flat 10–12% mutual fund assumption held constant with no accounting for volatility or investor behavior, applied to one specific policy design as if it represented the whole category.

Can you lose money in a cash value life insurance policy?

Yes, in two specific scenarios. First, surrendering a policy in its early years will typically return less than what you paid in premiums, since the front-loaded costs haven't been offset yet. Second, if you own variable universal life, your cash value sits directly in market subaccounts with no floor — the underlying principal can decline, as mine did.

What happens if I overfund my policy to maximize this fixed-income comparison?

Funding a policy above its guideline minimum — commonly through paid-up additions — isn't just acceptable, it's usually the single biggest lever available for improving the early-years curve I described earlier in this article. A larger share of each premium dollar routes directly into cash value rather than continuing to fund the base death benefit's cost structure, which compresses the flat-to-negative years and moves breakeven earlier. This is standard, deliberate policy design, not a loophole.

There's a specific ceiling, though, and it's worth understanding precisely rather than treating "overfunding" as one vague risk. Federal law caps how much can be paid into a policy over its first seven years relative to its death benefit — the 7-pay test. Fund within that limit and you get the faster breakeven described above, with no change to the policy's tax treatment. Cross it and the contract becomes a Modified Endowment Contract: the death benefit and guarantees stay intact, but the cash value permanently loses the tax-favored loan and withdrawal treatment that the fixed-income comparison in this article depends on. That's a specific, calculable line — not a matter of degree — which is exactly why funding levels need to be tested and designed at issuance by someone running the actual numbers, not estimated after the fact. Full mechanics are covered in What Is a Modified Endowment Contract?

Back to the Question

Is cash value life insurance a good investment? It's not an investment at all, in the strict sense — that's the honest starting point, not a technicality. Graded as a speculative growth engine, it loses to equities, and no honest version of this article pretends otherwise. Graded as a contractually guaranteed, tax-deferred alternative to the cash and fixed-income slice of a portfolio — measured over the long term, and set honestly against what a perpetual AUM fee actually costs over decades — it holds up considerably better than the spreadsheet wars would have you believe.

Jordan didn't reply to the roommate's email that night, and didn't post in the forum thread either. Both were answering questions Jordan hadn't actually asked yet.

For the mechanics behind how cash value actually accumulates inside a policy, start with our complete guide to how cash value life insurance works. If dividend-funded growth specifically is what you're trying to understand, see Dividend Options Explained. And if you're weighing this against your Roth IRA specifically, that direct comparison is in Cash Value Life Insurance vs. Roth IRA.

Still not sure whether this fits your specific numbers? Our free Decision Guide walks through your situation in about five minutes, with no sales call required to get an answer.

Jordan is a composite drawn from conversations I've had many times over — not any one client.

Everything above is general education, not individualized advice for your specific situation. Contract provisions, dividend scales, and crediting rates vary by insurer and by state, and your own numbers will differ from any example above. I'm a licensed insurance agent who sells whole life insurance and places indexed universal life, and I'm also a fee-only CFP® through Stormathrive Wealth Management, where I run a fee-based advisory practice — which is exactly why I've been direct about my own stake in the fee-structure comparison in this article, rather than leaving it out. If you want help figuring out where you land, you can find my background at my author profile.